Germline polymorphisms of the VEGF-pathway predict recurrence in non-advanced differentiated thyroid cancer | Zendy

Vincenzo Marotta | Zendy; Concetta Sciammarella | Zendy; Mario Capasso | Zendy; Alessandro Testori | Zendy; Claudia Pivonello | Zendy; Maria Grazia Chiofalo | Zendy; Claudio Gambardella | Zendy; Marica Grasso | Zendy; A Antonino | Zendy; Annamaria Annunziata | Zendy; Paolo Emidio Macchia | Zendy; Rosario Pivonello | Zendy; Luigi Santini | Zendy; Gerardo Botti | Zendy; Simona Losito | Zendy; Luciano Pezzullo | Zendy; Annamaria Colao | Zendy; Antongiulio Faggiano | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Germline polymorphisms of the VEGF-pathway predict recurrence in non-advanced differentiated thyroid cancer

Author(s) -

Vincenzo Marotta,

Concetta Sciammarella,

Mario Capasso,

Alessandro Testori,

Claudia Pivonello,

Maria Grazia Chiofalo,

Claudio Gambardella,

Marica Grasso,

A Antonino,

Annamaria Annunziata,

Paolo Emidio Macchia,

Rosario Pivonello,

Luigi Santini,

Gerardo Botti,

Simona Losito,

Luciano Pezzullo,

Annamaria Colao,

Antongiulio Faggiano

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2555

Subject(s) - single nucleotide polymorphism , medicine , thyroid cancer , genotype , odds ratio , gastroenterology , oncology , confidence interval , breast cancer , angiogenesis , vascular endothelial growth factor , pathology , cancer , biology , vegf receptors , genetics , gene

Tumor angiogenesis is determined by host genetic background rather than environment. Germline single nucleotide polymorphisms (SNPs) of the vascular endothelial growth factor (VEGF) pathway have demonstrated prognostic value in different tumors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research